Neurofilament ELISA validation

Journal of Immunological Methods

Volumn 352, Issue 1-2, 2010, Pages 23-31

  Petzold, Axel ^a   Altintas, Ayse ^b   Andreoni, Laura ^c   Bartos, Ales ^d,e   Berthele, Achim ^f   Blankenstein, Marinus A ^g   Buee, Luc ^h   Castellazzi, Massimiliano ⁱ   Cepok, Sabine ^f   Comabella, Manuel ^j   Constantinescu, Cris S ^k   Deisenhammer, Florian ^l   Deniz, Gunnur ^m   Erten, Gaye ^m   Espiño, Mercedes ⁿ   Fainardi, Enrico ^o   Franciotta, Diego ^c   Freedman, Mark S ^p   Giedraitis, Vilmantas ^y   Gilhus, Nils Erik ^q,r   Giovannoni, Gavin ^s   Glabinski, Andrzej ^t   Grieb, Pawel ^u   Hartung, Hans Peter ^v   Hemmer, Bernhard ^f   Herukka, Sanna Kaisa ^w   Hintzen, Rogier ^x   Ingelsson, Martin ^y   Jackson, Samuel ^s   Jacobsen, Steve ^z   Jafari, Naghmeh ^x   Jalosinski, Marcin ^t   Jarius, Sven ^aa   Kapaki, Elisabeth ^ab   Kieseier, Bernd C ^v   Koel Simmelink, Marleen J A ^g   Kornhuber, Johannes ^ac   Kuhle, Jens ^ad   Kurzepa, Jacek ^ae   Lalive, Patrice H ^af,ag   Lannfelt, Lars ^y   Lehmensiek, Vera ^ah   Lewczuk, Piotr ^ac   Livrea, Paolo ^ai   Marnetto, Fabiana ^aj   Martino, Davide ^ai   Menge, Til ^v   Norgren, Niklas ^ak   Papuć, Eva ^ae   Paraskevas, George P ^ab   Pirttilä, Tuula ^w   Rajda, Cecília ^al   Rejdak, Konrad ^ae   Ricny, Jan ^d   Ripova, Daniela ^d   Rosengren, Lars ^am   Ruggieri, Maddalena ^ai   Schraen, Susanna ^h   Shaw, Gerry ^an   Sindic, Christian ^ao   Siva, Aksel ^b   Stigbrand, Torgny ^ap   Stonebridge, Iva ^p   Topcular, Baris ^aq   Trojano, Maria ^ai   Tumani, Hayrettin ^ah   Twaalfhoven, Harry A M ^g   Vécsei, László ^al   Van Pesch, Vincent ^ao   Vanderstichele, Hugo ^ar   Vedeler, Christian ^q,r   Verbeek, Marcel M ^as   Villar, Luisa Maria ⁿ   Weissert, Robert ^at   Wildemann, Brigitte ^aa   Yang, Cui ^an   Yao, Karen ^z   Teunissen, Charlotte E ^g   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ISTANBUL UNIVERSITY   (Turkey)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^e CHARLES UNIVERSITY   (Czech Republic)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h JEAN PIERRE AUBERT RESEARCH CENTER   (France)

ⁱ Sezione di Clinica Neurologica   (Italy)

^j Centre d Esclerosi Múltiple de Catalunya Cemcat   (Spain)

^k UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^l INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^m ISTANBUL UNIVERSITY   (Turkey)

ⁿ HOSPITAL RAMÓN Y CAJAL   (Spain)

^o UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^p OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^q UNIVERSITY OF BERGEN   (Norway)

^r HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^s QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^t MEDICAL UNIVERSITY OF LODZ   (Poland)

^u POLISH ACADEMY OF SCIENCES   (Poland)

^v HEINRICH HEINE UNIVERSITY   (Germany)

^w KUOPIO UNIVERSITY HOSPITAL   (Finland)

^x ERASMUS MEDICAL CENTER   (Netherlands)

^y UPPSALA UNIVERSITY   (Sweden)

^z NATIONAL INSTITUTES OF HEALTH   (United States)

^aa UNIVERSITY OF HEIDELBERG   (Germany)

^ab NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^ac Universitaesklinikum Erlangen ^*  (Germany)

^ad UNIVERSITY HOSPITAL BASEL   (Switzerland)

^ae MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^af Department of Neurosciences   (Switzerland)

^ag GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^ah UNIVERSITY OF ULM   (Germany)

^ai UNIVERSITY OF BARI   (Italy)

^aj SAN LUIGI GONZAGA HOSPITAL   (Italy)

^ak UmanDiagnostics AB   (Sweden)

^al UNIVERSITY OF SZEGED   (Hungary)

^am SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^an UNIVERSITY OF FLORIDA   (United States)

^ao Neurochemistry Unit   (Belgium)

^ap UMEÅ UNIVERSITY   (Sweden)

^aq Bakirköy Mental Health and Neurological Diseases Training and Research Hospital   (Turkey)

^ar INNOGENETICS   (Belgium)

^as RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^at UNIVERSITY OF GENEVA   (Switzerland)

more..

Author keywords

Biomarker; NEFL; Neurofilament; NF L; NfL; Validation

Indexed keywords

NEUROFILAMENT PROTEIN;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; PROTEIN DETERMINATION; VALIDATION PROCESS;

BIOLOGICAL MARKERS; CELL DEATH; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEUROFILAMENT PROTEINS; NEURONS; OBSERVER VARIATION; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; TEMPERATURE; TIME FACTORS;

EID: 72049101865     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.09.014     Document Type: Article

References (23)

1. Blankenstein M.A., Clark C., De Deyn P.P., Galasko D., Hartmann T., Hampel H., Kapaki E., Mehta P.D., Parnetti L., Pirttila T., Verbeek M.M., Wildfang J., Blennow K., and Verbeek M.M. Multicenter comparison of assays for cerebrospinal fluid (CSF) markers for Alzheimer disease. Clin. Chim. Acta vol. 355 (2005) S175
2. Blennow K., de Leon M.J., and Zetterberg H. Alzheimer's disease. Lancet 368 (2006) 387
3. Carraro P., and Plebani M. Errors in a stat laboratory: types and frequencies 10 years later. Clin. Chem. 53 (2007) 1338
4. Carter J., Gragerov A., Konvicka K., et al. Neurofilament (NF) assembly; divergent characteristics of human and rodent NF-L subunits. J. Biol. Chem. 273 (1998) 5101
5. Constantinescu R., Romer M., Oakes D., Rosengren L., and Kieburtz K. Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease. Parkinsonism Relat. Disord. 15 3 (2009) 245
6. Dubois B., Feldman H.H., Jacova C., Dekosky S.T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P.J., and Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6 8 (2007) 734
7. Fleiss J.L. Measuring nominal scale agreement among many raters. Psychol. Bull. 76 (1971) 378
8. Gwet A. Handbook of Inter-Rater Reliability (2002), STATAXIS Publishing Company, Montgomery Village, MD 20886. USA
9. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159
10. Lee M.K., Xu Z., Wong P.C., and Cleveland D.W. Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol. 122 6 (1993) 1337 September
11. Lewczuk P., and Wiltfang J. Neurochemical dementia diagnostics: state of the art and research perspectives. Proteomics 8 (2008) 1292
12. Lewczuk P., Beck G., Ganslandt O., Esselmann H., Deisenhammer F., Regeniter A., Petereit H.F., Tumani H., Gerritzen A., Oschmann P., Schroder J., Schonknecht P., Zimmermann K., Hampel H., Burger K., Otto M., Haustein S., Herzog K., Dannenberg R., Wurster U., Bibl M., Maler J.M., Reubach U., Kornhuber J., and Wiltfang J. International quality control survey of neurochemical dementia diagnostics. Neurosci. Lett. 409 (2006) 1
13. Liem R.K., and Hutchison S.B. Purification of individual components of the neurofilament triplet: filament assembly from the 70 000-dalton subunit. Biochemistry 21 13 (1982) 3221 June
14. Norgren N., Karlsson J.E., Rosengren L., and Stigbrand T. Monoclonal antibodies selective for low molecular weight neurofilaments. Hybrid Hybridomics 21 (2002) 53
15. Norgren N., Rosengren L., and Stigbrand T. Elevated neurofilament levels in neurological diseases. Brain Res. 987 1 (2003) 25 October
16. Norgren N., Sundstrom P., Svenningsson A., Rosengren L., Stigbrand T., and Gunnarsson M. Neurofilament and glial fibrillary acidic protein in multiple sclerosis. Neurology 63 (2004) 1586
17. Perez-Olle R., Leung C.L., and Liem R.K. Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation. J. Cell Sci. 115 (2002) 4937
18. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration & loss. J. Neurol. Sci. 233 (2005) 183
19. Rosengren L.E., Karlsson J.E., Karlsson J.O., Persson L.I., and Wikkelso C. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J. Neurochem. 67 (1996) 2013
20. Shaw G. Neurofilaments (1998), Springer-Verlag
21. Teunissen C.E., Dijkstra C., and Polman C. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol. 4 (2005) 32-41
22. Van Geel W.J.A., Rosengren L.E., and Verbeek M.M. An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid. J. Immunol. Methods 296 (2005) 179
23. Verwey N.A., van der Flier W.M., Blennow K., Clark C., Sokolow S., De Deyn P.P., Galasko D., Hampel H., Hartmann T., Kapaki E., Lannfelt L., Mehta P.D., Parnetti L., Petzold A., Pirttila T., Saleh L., Skinningsrud A., Swieten J.C.V., Verbeek M.M., Wiltfang J., Younkin S., Scheltens P., and Blankenstein M.A. A worldwide multicenter comparison of assays for CSF biomarkers in Alzheimer disease. Ann. Clin. Biochem. 46 3 (2009) 235